Skip to main content

View full-text article in PMC

. 2019 Aug 20;7(19):3177–3183. doi: 10.3889/oamjms.2019.297

Table 1.

Characteristics of patients before treatment

	HBOT (n = 16)	Control (n = 16)	p value
Age (years)^a	52.56 ± 5.81	52.75 ± 5.17	0.924^b
DFUs duration (weeks)^a	5.75 ± 4.19	7.53 ± 12.98	0.779^c
DM duration (years)^a	6.33 ± 6.81	6.75 ± 6.16	0.319^c
BMI (kg/m²)	23.43 ± 3.86	23.99 ± 4.23	0.687^c
TcPO₂ (mmHg)^a	58.11 ± 4.87	59.18 ± 12.94	0.759^b
Random blood sugar (mg/dl)^a	238.00 ± 106.55	266.50 ± 122.40	0.488^b
Albumin serum (mg/dl)^a	3.08 ± 0.75	2.92 ± 0.55	0.692^d
Sex (%)
Male	8 (50)	5 (31.25)	0.280^e
Female	8 (50)	11 (68.75)

^a

Mean ± standard deviation; ⁱndependent T-test;

^c

Ln Independent T-test;

^d

Mann-Whitney U test;

^e

Chi-square test.